[go: up one dir, main page]

NO20003141D0 - Farmasøytiske blandinger - Google Patents

Farmasøytiske blandinger

Info

Publication number
NO20003141D0
NO20003141D0 NO20003141A NO20003141A NO20003141D0 NO 20003141 D0 NO20003141 D0 NO 20003141D0 NO 20003141 A NO20003141 A NO 20003141A NO 20003141 A NO20003141 A NO 20003141A NO 20003141 D0 NO20003141 D0 NO 20003141D0
Authority
NO
Norway
Prior art keywords
pharmaceutical mixtures
pharmaceutical
mixtures
Prior art date
Application number
NO20003141A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003141L (no
Inventor
Susan Jane Corvari
Joseph Richard Creekmore
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of NO20003141L publication Critical patent/NO20003141L/no
Publication of NO20003141D0 publication Critical patent/NO20003141D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20003141A 1997-12-18 2000-06-16 Farmasøytiske blandinger NO20003141D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726735.5A GB9726735D0 (en) 1997-12-18 1997-12-18 Pharmaceutical compositions
PCT/GB1998/003765 WO1999032082A2 (en) 1997-12-18 1998-12-15 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO20003141L NO20003141L (no) 2000-06-16
NO20003141D0 true NO20003141D0 (no) 2000-06-16

Family

ID=10823809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003141A NO20003141D0 (no) 1997-12-18 2000-06-16 Farmasøytiske blandinger

Country Status (30)

Country Link
US (1) US6399104B1 (id)
EP (1) EP1041966B1 (id)
JP (1) JP2001526206A (id)
KR (1) KR20010033206A (id)
CN (1) CN1282244A (id)
AR (1) AR017884A1 (id)
AT (1) ATE243999T1 (id)
AU (1) AU744326C (id)
BR (1) BR9813666A (id)
CA (1) CA2313163A1 (id)
DE (1) DE69816124T2 (id)
DK (1) DK1041966T3 (id)
EE (1) EE04260B1 (id)
ES (1) ES2202915T3 (id)
GB (1) GB9726735D0 (id)
HU (1) HUP0004669A3 (id)
ID (1) ID25857A (id)
IL (1) IL136501A0 (id)
IN (1) IN191311B (id)
MY (1) MY133096A (id)
NO (1) NO20003141D0 (id)
NZ (1) NZ504566A (id)
PL (1) PL341736A1 (id)
PT (1) PT1041966E (id)
RU (1) RU2205006C2 (id)
SK (1) SK9402000A3 (id)
TR (1) TR200001713T2 (id)
UA (1) UA62991C2 (id)
WO (1) WO1999032082A2 (id)
ZA (1) ZA9811532B (id)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
MX2009001636A (es) * 2006-08-16 2009-02-23 Novartis Ag Metodo para elaborar dispersiones solidas de compuestos terapeuticos altamente cristalinos.
EP2143424A4 (en) * 2007-03-26 2013-07-31 Teikoku Seiyaku Kk ORAL PHARMACEUTICAL PREPARATION FOR SPECIFIC DELIVERY TO THE COLON
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
WO2018140858A1 (en) 2017-01-30 2018-08-02 Western New England University Thiol isomerases inhibitors and use thereof
CN107714694A (zh) * 2017-11-01 2018-02-23 天津国际生物医药联合研究院 扎鲁司特在抗结核分枝杆菌感染中的应用
US20220370401A1 (en) 2021-05-19 2022-11-24 Quercis Pharma AG Method for treating amyotrophic lateral sclerosis using quercetin-containing compositions
EP4518852A1 (en) 2022-05-06 2025-03-12 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
AU744326B2 (en) 2002-02-21
TR200001713T2 (tr) 2000-10-23
SK9402000A3 (en) 2001-01-18
GB9726735D0 (en) 1998-02-18
JP2001526206A (ja) 2001-12-18
ATE243999T1 (de) 2003-07-15
WO1999032082A3 (en) 1999-09-16
HUP0004669A1 (hu) 2001-08-28
ID25857A (id) 2000-11-09
BR9813666A (pt) 2000-10-10
CN1282244A (zh) 2001-01-31
KR20010033206A (ko) 2001-04-25
EP1041966A2 (en) 2000-10-11
AU1571199A (en) 1999-07-12
HUP0004669A3 (en) 2005-03-29
AR017884A1 (es) 2001-10-24
WO1999032082A2 (en) 1999-07-01
DK1041966T3 (da) 2003-10-06
UA62991C2 (en) 2004-01-15
EE04260B1 (et) 2004-04-15
CA2313163A1 (en) 1999-07-01
DE69816124T2 (de) 2004-05-06
EE200000330A (et) 2001-08-15
NO20003141L (no) 2000-06-16
ZA9811532B (en) 1999-06-18
DE69816124D1 (de) 2003-08-07
IN191311B (id) 2003-11-22
RU2205006C2 (ru) 2003-05-27
PT1041966E (pt) 2003-11-28
ES2202915T3 (es) 2004-04-01
PL341736A1 (en) 2001-05-07
EP1041966B1 (en) 2003-07-02
NZ504566A (en) 2002-10-25
IL136501A0 (en) 2001-06-14
US6399104B1 (en) 2002-06-04
AU744326C (en) 2002-11-07
MY133096A (en) 2007-10-31

Similar Documents

Publication Publication Date Title
NO20001776D0 (no) Medikamenter
NO985337D0 (no) Tetrahydrolipstatin-holdige blandinger
ID24654A (id) Formulasi farmasi omeprazola
DK0783302T3 (da) Lægemidler
ID24176A (id) Bahan pembantu sementasi
DK1040051T3 (da) Blisterpakning
NO980546D0 (no) Farmasöytiske midler
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
DE69820407D1 (de) Blisterpackung
NO985539D0 (no) Farmas°ytiske blandinger
DK1017392T3 (da) Lægemiddel
ID27150A (id) Sediaan levotiroksin bahan farmasi
IS5331A (is) Ný lyfjablanda
IS2150B (is) Statín-karboxýalkýleter-blöndur
NO994619L (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
DE69926012D1 (de) Arzneizubereitungen
DE69906934D1 (de) Arzneizubereitungen
ATE238786T1 (de) Anti-first-pass-effect-substanzen
ID23531A (id) Komposisi farmasi
ID21180A (id) Senyawa-senyawa farmasi
FR2772264B1 (fr) Pilulier
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
BR1100755A (pt) composição farmacêutica
UA25523A (uk) Лікувальhий препарат гірчичhик

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application